GO:1903467 negative regulation of mitotic DNA replication initiation: Cell Cycle Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903467 describes any process that stops, prevents, or reduces the frequency, rate, or extent of DNA replication initiation specifically during mitotic DNA replication.
• This negative regulation is essential to ensure that each origin of replication fires only once per cell cycle, preventing re-replication and genomic instability.
• Key molecular players include cyclin-dependent kinases (CDKs), the Wee1 kinase, Cdc25 phosphatases, and licensing factors such as Cdt1 and Cdc6.
• Deregulation of this process is linked to cancer, as loss of control can lead to aneuploidy and DNA damage.
• Experimental models for studying this term include knockout, point-mutation, and overexpression cell lines, as well as CRISPR library screening.
• Understanding GO:1903467 provides insights into cell cycle checkpoints, replication stress responses, and potential therapeutic targets in oncology.
Description
The initiation of DNA replication is a tightly regulated event that ensures the genome is duplicated exactly once per cell cycle. In mitotic cells, this process must be coordinated with cell division to maintain genomic integrity. GO:1903467, negative regulation of mitotic DNA replication initiation, encompasses the molecular mechanisms that inhibit or delay the firing of replication origins during mitosis. This regulation is critical for preventing re-replication and for responding to cellular stresses such as DNA damage. Researchers study this term to understand how cells control replication timing and how its dysregulation contributes to diseases like cancer. The QuickGO definition states: Any process that stops, prevents or reduces the frequency, rate or extent of DNA replication initiation involved in mitotic DNA replication. This article explores the biological significance, key genes, and experimental approaches for investigating this regulatory process.
negative regulation of mitotic DNA replication initiation At A Glance
| GO ID | GO:1903467 |
|---|---|
| GO term | negative regulation of mitotic DNA replication initiation |
| Ontology | biological_process |
| Synonym | inhibition of DNA replication initiation involved in mitotic DNA replication; downregulation of DNA replication initiation involved in mitotic cell cycle DNA replication |
| Major function | Prevents re-replication and coordinates replication with mitosis |
| Related processes | Cell cycle checkpoints, DNA damage response, replication licensing |
| Key regulators | CDKs, Wee1, Cdc25, Cdt1, Cdc6, geminin |
| Disease relevance | Cancer, genomic instability, developmental disorders |
What Is GO:1903467?
GO:1903467 is a biological process term that refers to any mechanism that negatively regulates the initiation step of DNA replication during the mitotic cell cycle. It includes processes that inhibit the assembly of pre-replicative complexes, block the activation of replication origins, or delay the onset of DNA synthesis in mitosis. This regulation ensures that replication occurs only once per cycle and is responsive to cellular conditions.
Why Is negative regulation of mitotic DNA replication initiation Important in Cell Biology?
Negative regulation of mitotic DNA replication initiation is crucial for maintaining genomic stability. Without proper control, cells may re-replicate their DNA, leading to aneuploidy and DNA damage, which are hallmarks of cancer. This process also integrates signals from cell cycle checkpoints and stress responses, allowing cells to pause replication under unfavorable conditions. Understanding GO:1903467 is therefore essential for cancer research, developmental biology, and the development of targeted therapies.
• Prevents re-replication and maintains genomic integrity.
• Coordinates DNA replication with cell cycle progression and mitosis.
• Responds to DNA damage and replication stress.
• Dysregulation leads to aneuploidy and cancer.
• Involved in cellular senescence and aging.
• Target for cancer therapeutics, e.g., Wee1 inhibitors.
• Essential for normal development and tissue homeostasis.
• Provides insights into checkpoint control mechanisms.
What Happens During negative regulation of mitotic DNA replication initiation?
Inhibition of Pre-Replicative Complex Assembly
In simple terms: The cell blocks the loading of proteins that start DNA copying.
Negative regulation of mitotic DNA replication initiation often involves preventing the assembly of pre-replicative complexes (pre-RCs) at origins. This is achieved by inhibiting the loading of the MCM2-7 helicase by Cdt1 and Cdc6, or by promoting the degradation of these licensing factors. For example, geminin inhibits Cdt1, preventing re-licensing during mitosis.
CDK-Mediated Phosphorylation of Origin Proteins
In simple terms: Cyclin-dependent kinases add phosphate groups to replication proteins to shut them down.
Cyclin-dependent kinases (CDKs) phosphorylate components of the pre-RC, such as Cdc6 and MCM proteins, leading to their inhibition or degradation. This phosphorylation prevents the re-assembly of pre-RCs after origin firing, ensuring once-per-cycle replication. CDK activity is high during mitosis, reinforcing the block on re-initiation.
Role of Wee1 Kinase and Cdc25 Phosphatase
In simple terms: Wee1 acts as a brake, while Cdc25 acts as a gas pedal for cell cycle progression.
Wee1 kinase phosphorylates CDKs to inhibit their activity, thereby negatively regulating replication initiation. Conversely, Cdc25 phosphatases remove inhibitory phosphates to activate CDKs. The balance between Wee1 and Cdc25 controls the timing of mitosis and replication initiation. Wee1 inhibitors are being explored as anticancer agents because they force cells into mitosis with damaged DNA.
Checkpoint Control and Stress Responses
In simple terms: When cells are stressed, they hit the brakes on DNA copying.
DNA damage or replication stress activates checkpoint pathways (e.g., ATR, ATM) that inhibit CDK activity and block replication initiation. This negative regulation allows time for repair and prevents the propagation of damaged DNA. The integrated stress response can also modulate replication initiation under stress conditions.
Key Genes Involved in GO:1903467 negative regulation of mitotic DNA replication initiation
The following genes and proteins are key players in the negative regulation of mitotic DNA replication initiation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDK1 | Phosphorylates pre-RC components to inhibit re-initiation | Target for cell cycle inhibitors |
| WEE1 | Kinase that inhibits CDK1, blocking mitosis entry | Target for cancer therapy (Wee1 inhibitors) |
| CDC25 | Phosphatase that activates CDKs | Opposes Wee1; regulates timing |
| CDT1 | Licensing factor for MCM loading | Degraded by CDK to prevent re-replication |
| CDC6 | Required for MCM loading | Phosphorylated by CDK for inhibition |
| MCM2-7 | Helicase complex for replication | Phosphorylated to prevent re-loading |
| GEMININ | Inhibits Cdt1 | Prevents re-licensing during mitosis |
| ORC1-6 | Origin recognition complex | Phosphorylated by CDK |
| ATM | DNA damage checkpoint kinase | Inhibits replication initiation upon damage |
| ATR | Replication stress checkpoint kinase | Inhibits origin firing |
| CHK1 | Effector kinase downstream of ATR | Inhibits CDK activity |
| CHK2 | Effector kinase downstream of ATM | Inhibits CDK activity |
| P53 | Tumor suppressor, induces p21 | Inhibits CDK, blocks replication |
| P21 | CDK inhibitor | Mediates p53-dependent arrest |
| RB | Retinoblastoma protein | Regulates E2F, controls replication genes |
| E2F | Transcription factor for replication genes | Inhibited by RB |
| SKP2 | Ubiquitin ligase for p27 | Regulates CDK activity |
| APC/C | Ubiquitin ligase | Degrades geminin and cyclins |
How Is negative regulation of mitotic DNA replication initiation Regulated?
The negative regulation of mitotic DNA replication initiation is controlled by multiple signaling pathways. CDK activity is central, as high CDK levels inhibit pre-RC assembly. The Wee1 kinase and Cdc25 phosphatase pair regulates CDK1 activity, thereby controlling entry into mitosis and the block on replication initiation. Checkpoint kinases ATM, ATR, CHK1, and CHK2 respond to DNA damage and replication stress by inhibiting CDKs, reinforcing the negative regulation. Additionally, the integrated stress response can modulate replication initiation under stress conditions.
negative regulation of mitotic DNA replication initiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WEE1 | Cancer (p53-mutant tumors) | Knockout or point-mutation cell lines; Wee1 inhibitor treatment |
| CDT1 | Cancer, re-replication | Overexpression cell model; knockout |
| CDC6 | Cancer, Meier-Gorlin syndrome | Knock-in of patient mutations |
| ATM | Ataxia-telangiectasia, cancer | Knockout cell lines |
| ATR | Seckel syndrome, cancer | Knockout or knockdown models |
Cancer and Genomic Instability
Deregulation of negative regulation of mitotic DNA replication initiation leads to re-replication, aneuploidy, and DNA damage, which are hallmarks of cancer. Overexpression of licensing factors like Cdt1 or loss of checkpoint control can drive tumorigenesis. Targeting Wee1 kinase, a key negative regulator, has emerged as a therapeutic strategy in cancers with p53 mutations.
Aging and Cellular Senescence
Restricting the levels of proteins essential for replication initiation extends chronological lifespan in budding yeast, suggesting a link between negative regulation of replication initiation and aging. This highlights the importance of tight control over replication for longevity.
Developmental Disorders
Proper control of replication initiation is critical during development. Mutations in genes involved in this process can cause developmental defects due to genomic instability and impaired cell proliferation.
From negative regulation of mitotic DNA replication initiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate replication initiation? | Knockout cell line (e.g., CRISPR-Cas9) |
| Does a specific mutation affect CDK inhibition? | Point-mutation knock-in cell line |
| How does overexpression of licensing factor affect re-replication? | Overexpression cell line |
| Where does protein X localize during mitosis? | Tagged knock-in (e.g., GFP) cell line |
| What are the downstream targets of Wee1? | CRISPR library screening with Wee1 inhibitor |
| How does stress affect replication initiation? | Reporter cell line with replication stress markers |
How to Study the negative regulation of mitotic DNA replication initiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identify regulators of replication initiation |
| Live-cell imaging | Origin firing dynamics | Visualize re-replication in real time |
| Phosphoproteomics | Phosphorylation sites on replication proteins | Map CDK substrates |
| Flow cytometry | DNA content and cell cycle profile | Detect re-replication and arrest |
| RNA-seq | Transcriptional changes | Assess gene expression after knockdown |
| Proximity ligation assay | Protein-protein interactions | Study pre-RC assembly |
| Chromatin immunoprecipitation (ChIP) | Protein binding at origins | Measure MCM loading |
| Western blot | Protein levels and modifications | Validate knockdown/overexpression |
Genome-Wide CRISPR Screens
CRISPR library screening can identify genes that regulate mitotic DNA replication initiation. By treating cells with replication inhibitors or inducing stress, researchers can uncover synthetic lethal interactions and pathways that negatively regulate initiation.
Live-Cell Imaging of Replication Origins
Fluorescently tagged replication proteins (e.g., MCM, Cdt1) allow real-time visualization of origin firing and re-replication events in single cells. This method reveals the dynamics of negative regulation during mitosis.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies CDK substrates and phosphorylation events that inhibit replication initiation. This approach provides a global view of signaling networks controlling this process.
Flow Cytometry and DNA Content Analysis
Flow cytometry measures DNA content to detect re-replication (DNA content >4N) and cell cycle arrest. It is a classic method to assess the consequences of deregulated replication initiation.
How CRISPR Can Be Used to Study GO:1903467 negative regulation of mitotic DNA replication initiation
Knockout
CRISPR knockout of genes involved in negative regulation (e.g., WEE1, CDK1) can lead to premature or unscheduled replication initiation, causing DNA damage and cell death. These models are valuable for studying the consequences of losing control over replication timing.
Point Mutation
Introducing point mutations in phosphorylation sites of pre-RC components (e.g., Cdc6, MCM) using CRISPR can reveal how specific modifications regulate initiation. Such models help dissect signaling pathways without completely abolishing protein function.
Knock-in
Knock-in of tagged versions of replication proteins (e.g., GFP-Cdt1) allows real-time tracking of their localization and dynamics. This approach is powerful for understanding how negative regulation is spatially and temporally controlled.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of licensing factors or inhibitors, mimicking pathological states. Overexpression of Cdt1, for example, induces re-replication and is used to study genomic instability.
How EDITGENE Supports negative regulation of mitotic DNA replication initiation Research
Researchers studying negative regulation of mitotic DNA replication initiation-related genes often need to determine whether a candidate gene is causally involved in the process or is merely a bystander. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitotic DNA replication initiation research.
Frequently Asked Questions About negative regulation of mitotic DNA replication initiation
What is GO:1903467?
GO:1903467 is a Gene Ontology term for negative regulation of mitotic DNA replication initiation, describing processes that stop or reduce the start of DNA replication during mitosis.
What genes are involved in negative regulation of mitotic DNA replication initiation?
Key genes include CDK1, WEE1, CDC25, CDT1, CDC6, MCM2-7, GEMININ, ATM, ATR, CHK1, CHK2, TP53, and RB.
Why is negative regulation of mitotic DNA replication initiation important?
It prevents re-replication and maintains genomic stability; its dysregulation leads to cancer and other diseases.
How is mitotic DNA replication initiation negatively regulated?
Through CDK-mediated phosphorylation of pre-RC components, checkpoint kinase activation, and inhibition of licensing factors.
What diseases are associated with defects in this process?
Cancer, genomic instability, and potentially developmental disorders and aging.
What experimental models are used to study GO:1903467?
Knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screens.
What is the role of Wee1 in this process?
Wee1 kinase inhibits CDK1, thereby preventing entry into mitosis and blocking replication initiation.
How does CDK regulate replication initiation?
CDKs phosphorylate pre-RC proteins, inhibiting their function and preventing re-assembly of replication complexes.
Can CRISPR be used to study negative regulation of mitotic DNA replication initiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect this process.
What methods are used to measure replication initiation?
Flow cytometry, live-cell imaging, ChIP, phosphoproteomics, and CRISPR screens.
Conclusion
GO:1903467, negative regulation of mitotic DNA replication initiation, is a critical biological process that safeguards genomic integrity by ensuring DNA is replicated only once per cell cycle. Its dysregulation is implicated in cancer and aging, making it a focal point for therapeutic development. Advanced CRISPR tools and screening methods continue to unravel the complex regulatory networks involved, offering new opportunities for intervention. EDITGENE supports these efforts with tailored cell model generation and bioinformatics services.
References
- 1. Shrestha S et al.. 2026. Mitotic kinase regulation of DNA replication forks.. bioRxiv PMID: 42239444
- 2. Tjeerdsma RB et al.. 2025. WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response.. Nat Commun 16(1):11598 PMID: 41285872
- 3. Stępień K et al.. 2024. Restricting the level of the proteins essential for the regulation of the initiation step of replication extends the chronological lifespan and reproductive potential in budding yeast.. Biogerontology 25(5):859-881 PMID: 38844751
- 4. Rhind N et al.. 2012. Signaling pathways that regulate cell division.. Cold Spring Harb Perspect Biol 4(10) PMID: 23028116
- 5. Balczon R et al.. 1995. Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells.. J Cell Biol 130(1):105-15 PMID: 7790366
- 6. Nandi S et al.. 2022. Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents.. Curr Med Chem 29(2):212-234 PMID: 33655823
- 7. Perry JA et al.. 2007. Cdc25 and Wee1: analogous opposites?. Cell Div 2:12 PMID: 17480229
- 8. Ito S et al.. 2012. Mechanism of cancer cell death induced by depletion of an essential replication regulator.. PLoS One 7(5):e36372 PMID: 22574151
